Close Menu

    Subscribe to Updates

    Get the latest creative news from FooBar about art, design and business.

    What's Hot

    SDCC teaser gives us our first good look at Blade Runner 2099

    July 25, 2026

    Flavio Bolsonaro launches Brazil presidential campaign, touts support from Milei, Netanyahu

    July 25, 2026

    Goldman Sachs raises TOPIX 12-month target to 4,500 on weaker yen outlook

    July 25, 2026
    Facebook X (Twitter) Instagram
    Addison Markets
    • Home
    • USA
    • Europe
    • Business
    • Investing
    • Tech
    • Politics
    • Contact Us
    Addison Markets
    Home»Tech»Routine vaccines may cut dementia risk—experts have startling hypothesis on how
    Tech

    Routine vaccines may cut dementia risk—experts have startling hypothesis on how

    franperez66q@protonmail.comBy franperez66q@protonmail.comMay 16, 2026No Comments2 Mins Read
    Facebook Twitter Pinterest Telegram LinkedIn Tumblr WhatsApp Email
    Share
    Facebook Twitter LinkedIn Pinterest Telegram Email



    A shot of a shingles vaccine blocks reactivation, potentially preventing the virus from triggering brain inflammation that could contribute to the development of dementia. Conversely, there’s some evidence that having shingles may increase the risk of dementia.

    A possible mechanism

    But not every vaccine linked to reduced dementia risk comes with such an explanation for how it may protect the brain. For example, the seasonal flu vaccine seems to reduce dementia, but it’s unclear how. Still, in a large retrospective study published last month, researchers again bolstered the link between the seasonal flu shot and lower risks of dementia, this time finding that high-dose seasonal flu shots given to older patients are yet more protective against dementia than standard doses.

    In other words, there seems to be a dose-dependent response—the higher the flu vaccine dose, the lower the dementia risk. The authors don’t speculate on how the seasonal shot could affect cognitive health, but they call for more research into potential mechanisms, including trained immunity.

    In the March hypothesis piece, published in the journal Frontiers in Immunology, Devine and colleagues hypothesize that trained immunity from vaccinations could indeed be responsible.

    “A central element in this immunological model is that uncontrolled or excessive levels of neuro-inflammation, associated with elevated dementia risk, can be counteracted by epigenetic reprogramming of innate immune cells,” they write.

    For instance, it may be that the nonspecific changes to innate responses from vaccines are able to keep both targeted and non-targeted pathogens in check, preventing brain inflammation from flaring up, they say.

    For now, the idea is just a hypothesis, and there’s a lot more work needed to validate it. But the stakes are high for pursuing it, the researchers argue. “Elucidating the mechanisms underlying these promising observations may open new avenues to promote healthy aging through vaccination and could be crucial for alleviating the global burden of dementia,” they write.



    Source link

    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
    franperez66q@protonmail.com
    • Website

    Related Posts

    SDCC teaser gives us our first good look at Blade Runner 2099

    July 25, 2026

    Here are 4 forces that drove a tough week for stocks

    July 25, 2026

    SpaceX eyes tower catch for next Starship after auspicious end to 13th flight

    July 25, 2026

    AI firms want more data centers; Trump’s EPA may give neighbors less say

    July 25, 2026

    Big Tech accused of stonewalling European social media researchers

    July 25, 2026

    With help from data, art museums are reframing the visitor experience

    July 25, 2026
    Leave A Reply Cancel Reply

    Top Reviews
    Editors Picks

    SDCC teaser gives us our first good look at Blade Runner 2099

    July 25, 2026

    Flavio Bolsonaro launches Brazil presidential campaign, touts support from Milei, Netanyahu

    July 25, 2026

    Goldman Sachs raises TOPIX 12-month target to 4,500 on weaker yen outlook

    July 25, 2026

    Here are 4 forces that drove a tough week for stocks

    July 25, 2026
    © 2026 All right reserved
    • Privacy Policy
    • Terms & Conditions

    Type above and press Enter to search. Press Esc to cancel.